PHASE II MULTICENTER TRIAL OF ERLOTINIB FOR ADVANCED NON-SMALL-CELL LUNG CANCER WITH EPIDERMAL GROWTH FACTOR RECEPTOR MUTATIONS
JOURNAL OF THORACIC ONCOLOGY（2013）
关键词
erlotinib,non-small-cell lung cancer,EGFR mutation,second-line treatment
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要